Share on LinkedInShare on LinkedIn

ARTICLE · 23 NOVEMBER 2023

Market Intelligence Thought Leadership Award Winner

Vital Signs: Digital Health Law Update | Fall 2023

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

We bring you Vital Signs, a curated, one-stop resource on the most notable digital health law updates from our U.S. and global contributors.

GlobalPrivacy

Note From the Editors

We bring you Vital Signs, a curated, one-stop resource on the most notable digital health law updates from our U.S. and global contributors. In Industry Insights, our lawyers describe the increasingly common regulation of digital health privacy by states. These state laws are far reaching, impacting digital health providers that primarily operate outside of the enacting states. In our U.S. Developments section, you'll read about Drug Enforcement Administration ("DEA") developments related to controlled substance prescribing, updates from the U.S. Food and Drug Administration ("FDA") on digital health technologies, and several significant state regulatory updates. In our Global Developments section, we highlight noteworthy digital health-related updates throughout Europe. Thank you to our contributors who are committed to bringing you curated updates covering digital health developments of interest.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from